logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Laurence Albigès

Université Paris-Saclay
H指数:83
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

57 Final Analysis of the TiNivo-2 Phase 3 Trial: Long-term Outcome of Tivozanib (Tivo) in Patients with Metastatic Renal Cell Carcinoma (mRCC)

57 TiNivo-2 III期试验的最终分析：替沃扎尼（Tivo）在转移性肾细胞癌（mRCC）患者中的长期结局

Oncologist
IF4.2
2026-09-020
OAAI
Robert Motzer; Bradley McGregor; Laurence Albiges; Javier Molina-Cerrillo; Phillipe Barthelemy; Maria Bourlon; Benjamin Garmezy; Sheik Emambux; Arnab Basu; Raffaele Ratta; Pedro Barata; Jeffrey Yorio; Helen Moon; Alex Chehrazi-Raffle; Roberto Iacovelli; Ralph Hauke; Rana McKay; Kathryn Beckermann; Moshe Ornstein; Toni Choueiri
Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review

乳头状肾细胞癌——基于中央病理学审查的SUNNIFORECAST试验探索性结果：比较伊匹木单抗联合纳武利尤单抗与标准护理作为一线治疗的疗效

European Journal of Cancer
IF7.1
2026-05-270
OAAI
Marit Ahrens; John Haanen; Laurence Albiges; Marine Gross Goupil; Ekaterini Boleti; Gwenaelle Gravis; Aude Fléchon; Marc Oliver Grimm; Jens Bedke; Philippe Barthélémy; Daniel Castellano; Begona Mellado; Philipp Ivanyi; Sylvie Rottey; Anne Flörcken; Cristina Suárez; Jose P. Maroto; Viktor Grünwald; Sjoukje Oosting; Jindrich Kopecky
Differential effects of prior versus concomitant Steroid and Antibiotic Treatment on Immunotherapy Efficacy - A Pooled Analysis of the RAMONA, INTEGA, OPTIM, ELDORANDO, FORCE, TITAN-RCC and TITAN-TCC Trials of the German AIO Study Group

既往与同期糖皮质激素和抗生素治疗对免疫治疗疗效的差异化影响——德国AIO研究组RAMONA、INTEGA、OPTIM、ELDORANDO、FORCE、TITAN-RCC和TITAN-TCC试验的合并分析

British Journal of Cancer
IF6.8
2026-05-190
OAAI
Isabella C. Wiest; Lena Dreikhausen; Ralph Keller; Marcos Marin-Galiano; Laurence Albiges; Johannes Meran; Katharina Leucht; Stefan Rieken; Emilio Esteban; Friedemann Zengerling; Joseph Tintelnot; Marc-Oliver Grimm; Farastuk Bozorgmehr; Petros Christopoulos; Alexander Stein; Mascha Binder; Nicolai Härtel; Konrad Klinghammer; Viktor Grünwald; Michael Pogorzelski; Matthias P. Ebert
Comprehensive Genomic and Transcriptomic Characterization of Matched Primary and Recurrent Tumors in High-risk Localized Renal Cell Carcinoma

高-risk 局部肾细胞癌配对的原发和复发肿瘤的全面基因组学和转录组学特征

European Urology
IF25.2
2026-04-250
PRE
Wenxin Xu; Brian I. Rini; Laurence Albiges; Xiaobin Tang; Hartmut Koeppen; Axel Bex; Cristina Suárez; Robert Uzzo; Viraj Master; Jose A. Karam; Habib Hamidi; Zoe June Assaf; Sarita Dubey; Erik T. Goluboff; Corey Carter; Romain Banchereau; Mahrukh A. Huseni; Sumanta Kumar Pal
Cabozantinib in Patients with Non-Locally Pretreated Brain Metastases from Renal Cell Carcinoma: Results of the Multicenter Phase II Trial CABRAMET

卡博齐坦在非局部预处理的肾细胞癌脑转移患者中的疗效：CABRAMET多中心II期试验结果

European Journal of Cancer
IF7.1
2026-04-010
PRE
Sylvie Negrier; Loïc Mourey; Cécile Dalban; Marine Gross-Goupil; Aude Fléchon; Bernard Escudier; Philippe Barthélémy; Stéphane Oudard; Emeline Colomba; Constance Thibault; Alain Ravaud; Christine Chevreau; Helen Jane Boyle; Ellen Blanc; Sylvie Chabaud; David Pérol; Laurence Albiges; Ronan Flippot
Erratum to “Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review”. [Cancer Treat. Rev. 140 (2025) 103024]

勘误：“脑转移对系统性肾细胞癌治疗效果的影响：一项系统文献综述”。[Cancer Treat. Rev. 140 (2025) 103024]

Cancer Treatment Reviews
IF10.5
2026-03-030
OAAI
Natalie Charnley; Kate Fife; Daniel Y.C. Heng; James Larkin; John McGrane; Sylvie Négrier; Naveen Vasudev; Balaji Venugopal; Alison Chisholm; Alessia Ogareva; Áine Prendergast; Laurence Albiges
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial☆

纳武利尤单抗联合伊匹木单抗与舒尼替尼用于晚期肾细胞癌一线治疗的疗效和安全性：III期CheckMate 214试验的最终分析

Annals of Oncology
IF65.4
2026-03-030
OAAI
T.K. Choueiri; L. Albigès; D.F. McDermott; H.J. Hammers; B. Escudier; M. Burotto; E.R. Plimack; C. Porta; S. George; T. Powles; F. Donskov; M.B. Atkins; H. Gurney; C.K. Kollmannsberger; M.-O. Grimm; C. Barrios; D. Castellano; V. Grünwald; Y. Tomita; B.I. Rini
Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care
British Journal of Cancer
IF6.8
2026-01-200
PRE
Benoit Blanchet; Alexandre Xu-Vuillard; Anne Jouinot; Florent Puisset; David Combarel; Olivier Huillard; Félicien Le Louedec; Fabienne Thomas; Marcus Teixeira; Ronan Flippot; Loic Mourey; Laurence Albiges; Thomas Pudlarz; Charlotte Joly; Christophe Tournigand; Jonathan Chauvin; Alicja Puszkiel; Etienne Chatelut; Xavier Decleves; Michel Vidal; François Goldwasser; Stéphane Oudard; Jacques Medioni; Yann-Alexandre Vano
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma
Nature Medicine
IF50
2026-01-070
OAAI
Carolina Alves Costa Silva; Marc Machaalani; Renee Maria Saliby; Caiwei Zhong; Wanling Xie; Edoardo Pasolli; Gianmarco Piccinno; Cécile Dalban; Marine Fidelle; Aurelia Meurisse; Dewi Vernerey; Gwo-Shu Mary Lee; Roxanne Birebent; Eddy Saad; Clara Steiner; Ronan Flippot; Janice Barros-Monteiro; Nicola Segata; Antoine Thiery-Vuillemin; Silvia Formenti; Tatiana Kuznetsova; Bernard Escudier; Lisa Derosa; Laurence Zitvogel; Toni K. Choueiri; Laurence Albiges
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers

高级泌尿肿瘤共识会议（AUC3）2025：肾细胞癌和尿路肿瘤管理的专家共识

CA: A Cancer Journal for Clinicians
IF0
2025-12-130
OAAI
Rana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
Peritoneal recurrence following nephrectomy for localized renal cancer: A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study-UroCCR 124)

局限性肾癌根治性肾切除术后的腹膜复发：一项多中心欧洲真实世界分析腹膜复发的发生率、模式及治疗（PEMET研究-UroCCR 124）

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
2025-12-010
PRE
Pettenati, Caroline; Bernhard, Jean-Christophe; Khene, Zine-Eddine; Capitanio, Umberto; Musso, Giacomo; Albiges, Laurence; Rainho, Larissa; Margue, Gaelle; Waeckel, Thibault; Verhoest, Gregory; Bento, Lucas; Doumerc, Nicolas; Surlemont, Louis; Neuzillet, Yann; Lebret, Thierry; Graafland, Niels; Dabestani, Saeed; Bex, Axel; Roupret, Morgan; Bensalah, Karim; Bigot, Pierre
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study

转移性透明细胞肾细胞癌中的Nivolumab: 来自NIVOREN getug-afu 26 2期研究的综合生物标志物分析

European Urology
IF25.2
2025-11-110
PRE
Ronan Flippot; Yann-Alexandre Vano; Cécile Dalban; Benoit Beuselinck; Aude Fléchon; Maxime Meylan; Damien Pouessel; Antoine Bougoüin; Catherine Sautes-Fridman; Gwenaelle Gravis; Nathalie Chaput; Stéphane Oudard; Aude Desnoyer; Brigitte Laguerre; Salem Chouaib; Philippe Barthelemy; Delphine Borchiellini; Lucia Carril-Ajuria; Marine Gross-Goupil; Wolf-Herman Fridman; Lionnel Geoffrois; Frederic Rolland; Antoine Thiery-Vuillemin; Florence Joly; Sylvain Ladoire; Florence Tantot; Sylvie Chabaud; Bernard Escudier; Nathalie Rioux-Leclercq; Laurence Albiges
Novel pembrolizumab-based treatments as first-line therapy in advanced clear cell renal cell carcinoma: Substudy 03A of the open-label, umbrella platform, phase I/II KEYMAKER-U03 trial

新型基于pembrolizumab的治疗方案作为晚期透明细胞肾细胞癌的一线疗法：开放标签、伞形平台、I/II期KEYMAKER-U03试验的子研究03A

Annals of Oncology
IF65.4
2025-10-180
PRE
C. Suarez; C. Rojas; S.J. Shin; P.Yanez Weber; L. Albiges; R. Motzer; H. Hammers; A. Peer; J-L. Lee; W.H. Miller; T. Waddell; V. Neiman; D. Keizman; A.Zwenger Kloster; A. Weickhardt; R. Dziadziuszko; L. Suttner; M. Sharma; J.E. Burgents; T. Powles
CaboPoint: A Phase 2 Study of Second-line Cabozantinib After Checkpoint Inhibitor–based Combination Therapy in Patients with Metastatic Renal Cell Carcinoma

CaboPoint：一项关于在转移性肾细胞癌患者中，在基于检查点抑制剂联合疗法之后进行二线卡博替尼治疗的研究

European Urology
IF25.2
2025-09-300
PRE
Laurence Albiges; Thomas Powles; Anand Sharma; Balaji Venugopal; Jens Bedke; Angelika Borkowetz; Gwenaelle Gravis; Berna C. Özdemir; Marco Julius Schnabel; Pascale Dutailly; Bryan Qvick; Valerie Perrot; Viktor Grünwald
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank

开发生物标志物和风险分层方法：国际肾癌研讨会北美2024年思辨研讨会的共识声明

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
IF2.3
2025-09-010
PRE
Shapiro, Daniel D.; Abel, Edwin Jason; Albiges, Laurence; Battle, Dena; Berg, Stephanie A.; Campbell, Matthew T.; Cella, David; Coleman, Katie; Garmezy, Benjamin; Geynisman, Daniel M.; Hall, Tasha; Henske, Elizabeth P.; Jonasch, Eric; Karam, Jose A.; La Rosa, Salvatore; Leibovich, Bradley C.; Maranchie, Jodi K.; Master, Viraj A.; Maughan, Benjamin L.; Mcgregor, Bradley A.; Msaouel, Pavlos; Pal, Sumanta K.; Perez, Jose; Plimack, Elizabeth R.; Psutka, Sarah P.; Riaz, Irbaz B.; Rini, Brian I.; Shuch, Brian; Simon, Marie Celeste; Singer, Eric A.; Smith, Andrew; Staehler, Michael; Tang, Chad; Tannir, Nizar M.; Vaishampayan, Ulka; Voss, Martin H.; Zakharia, Yousef; Zhang, Qing; Zhang, Tian; Carlo, Maria I.
Development of a Health-related Quality of Life Questionnaire for Patients with Metastatic or Localized Renal Cell Carcinoma

为转移性或局限性肾细胞癌患者开发健康相关生活质量问卷

European Urology Oncology
IF9.3
2025-08-190
PRE
Cristiane D. Bergerot; David Cella; Paulo G. Bergerot; Daniela V. Castro; Benjamin D. Mercier; Elizabeth Nally; Adil A. Ali; Errol J. Philip; Thomas Hutson; Axel Bex; Sarah P. Psutka; Brian Rini; Elizabeth R. Plimack; Viktor Grünwald; Viraj Master; Laurence Albiges; Toni K. Choueiri; Sumanta K. Pal; Thomas Powles

研究方向

暂未获取到该数据
B
Bernard Escudier
H 指数:121论文数:1,140被引数:8.9万
G
Gwénaëlle Gravis
H 指数:65论文数:736被引数:2.3万
T
Toni K. Choueiri
H 指数:149论文数:2,479被引数:12.7万
A
Axel Bex
H 指数:66论文数:619被引数:2.5万
Y
Yohann Loriot
H 指数:76论文数:1,129被引数:5.4万
K
Karim Fizazi
H 指数:123论文数:1,539被引数:8.3万
C
Christophe Massard
H 指数:78论文数:1,148被引数:2.4万
M
Marine Gross‐Goupil
H 指数:44论文数:322被引数:1.0万
R
Ronan Flippot
H 指数:26论文数:443被引数:2,791
T
Thomas Powles
H 指数:70论文数:528被引数:3.5万